The move received praise from Rep. Mark Pocan, D-Madison, whose district includes a breeding and research facility called Ridglan Farms On Monday, an animal rights nonprofit announced that Ridglan ...

The potential for a wider outbreak is low, but experts are still investigating how the disease-causing virus leaped from ...

Pennsylvania has enacted new restrictions on animal testing, requiring research facilities to provide adoption opportunities ...

Scat may be a waste product, but it holds crucial clues about an animal’s diet, disease risk and genetic health.

Experiments, testing and research with the use of animals have been drawing backlash from activists, politicians and the government. However, scientists say we still need to utilize animals to advance ...

The International Coalition of Medicines Regulatory Authorities (ICMRA) issued a joint statement encouraging manufacturers and national control laboratories to reduce animal testing throughout the ...

Please provide your email address to receive an email when new articles are posted on . The proposed rule would replace the word “animal” with “nonclinical” in references to studies and tests. The ...

Peach, a 6-year-old beagle, was once just called “CTU-9,” the number she was assigned at Ridglan Farms, a now-closed beagle breeding and research facility in Blue Mounds, Wisconsin. Peach’s former ...

Huron, N.Y. — The March to Abolish Animal Testing, a 207-mile, 14-day march from Albany to Marshall BioResources in Wayne County, is concluding on Saturday. The facility breeds animals including ...

A newly premiered documentary explores a growing question in biomedical research: Is animal testing still necessary, or can emerging technologies provide safe alternatives? “The New Gold Standard” ...

LYONS, N.Y. — Animal rights activists have been marching from Albany to Wayne County for the past 13 days to protest animal testing. The 207-mile march is set to end Saturday at Marshall BioResources ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...